D. Marona-Lewicka

发表

Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats

D. E. Nichols, D. Marona-Lewicka, D. Kurrasch-Orbaugh, 2002, Psychopharmacology.

Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.

D. E. Nichols, E. sanders-Bush, A. Kanthasamy, 1995, Journal of medicinal chemistry.

Lysergamides of isomeric 2,4-dimethylazetidines map the binding orientation of the diethylamide moiety in the potent hallucinogenic agent N,N-diethyllysergamide (LSD).

D. E. Nichols, D. Marona-Lewicka, D. Kurrasch-Orbaugh, 2002, Journal of medicinal chemistry.

Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.

D. E. Nichols, M. Lill, J. McCorvy, 2013, ACS chemical neuroscience.

Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines.

D. E. Nichols, V. Watts, E. Barker, 2001 .

1-(2,5-Dimethoxy-4-(trifluoromethyl)phenyl)-2-aminopropane: a potent serotonin 5-HT2A/2C agonist.

D. E. Nichols, B. Roth, D. Marona-Lewicka, 1994, Journal of medicinal chemistry.

Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives.

D. E. Nichols, E. sanders-Bush, D. Nelson, 1997, Journal of medicinal chemistry.

Drug discrimination studies of the interoceptive cues produced by selective serotonin uptake inhibitors and selective serotonin releasing agents

D. Marona-Lewicka, D. Nichols, 1998, Psychopharmacology.

Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines.

V. Watts, E. Barker, D. Marona-Lewicka, 2000, Journal of medicinal chemistry.

Substituted naphthofurans as hallucinogenic phenethylamine-ergoline hybrid molecules with unexpected muscarinic antagonist activity.

R. Mailman, D. Nelson, M. Lewis, 1998, Journal of medicinal chemistry.

Stereoselective pharmacological effects of lysergic acid amides possessing chirality in the amide substituent

D. Marona-Lewicka, A. Monte, X. Huang, 1995, Behavioural Brain Research.

Indan Analogs of Fenfluramine and Norfenfluramine Have Reduced Neurotoxic Potential

N. Cozzi, D. Marona-Lewicka, S. Frescas, 1998, Pharmacology Biochemistry and Behavior.

5-HT2A/2C receptor agonists potentiate the discriminative cue of (+)-amphetamine in the rat

D. Marona-Lewicka, D. Nichols, 1997, Neuropharmacology.

An animal model of schizophrenia based on chronic LSD administration: Old idea, new results

C. Nichols, D. Marona-Lewicka, D. Nichols, 2011, Neuropharmacology.

1-( 2 , 5-Dimethoxy-4-( trifluoromethy 1 ) phenyl )-2-aminopropane : A Potent Serotonin ~-H T ~ A / ~ c Agonist

B. Roth, D. Marona-Lewicka, G. Gudelsky, 2001 .

'Hybrid' benzofuran-benzopyran congeners as rigid analogs of hallucinogenic phenethylamines.

Jennifer A. Prescher, Danielle M. Schultz, S. Kidd, 2008, Bioorganic & medicinal chemistry.

1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists.

Michael R. Braden, T. H. Mclean, Alejandra Gallardo-Godoy, 2006, Journal of medicinal chemistry.

C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor.

Michael R. Braden, David E Nichols, J. Chambers, 2006, Journal of medicinal chemistry.

Synthesis and pharmacological characterization of a series of geometrically constrained 5-HT(2A/2C) receptor ligands.

Niels H. Jensen, J. Chambers, D. Marona-Lewicka, 2003, Journal of medicinal chemistry.

Substituted hexahydrobenzodipyrans as 5-HT2A/2C receptor probes.

D. Marona-Lewicka, D. Kurrasch-Orbaugh, A. Monte, 2002, Bioorganic & medicinal chemistry.

Synthesis and Pharmacological Characterization of a Series of Geometrically Constrained 5-HT 2 A / 2 C Receptor Ligands

Niels H. Jensen, J. Chambers, D. Marona-Lewicka, 2022 .

A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor.

D E Nichols, D. Nelson, D L Nelson, 1998, Journal of medicinal chemistry.

Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.

D. Nelson, M. Parker, D. B. Wainscott, 1996, Journal of medicinal chemistry.

Thieno[3,2-b]- and thieno[2,3-b]pyrrole bioisosteric analogues of the hallucinogen and serotonin agonist N,N-dimethyltryptamine.

D. Nelson, V. Lucaites, A. Kanthasamy, 1999, Journal of medicinal chemistry.

Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine.

N. Cozzi, D. Marona-Lewicka, A. Monte, 1993, Journal of medicinal chemistry.

Psychostimulant-like effects of p-fluoroamphetamine in the rat.

D. Marona-Lewicka, G. Rhee, D. Nichols, 1995, European journal of pharmacology.

Behavioral effects of the highly selective serotonin releasing agent 5-methoxy-6-methyl-2-aminoindan.

D. Marona-Lewicka, D. Nichols, 1994, European journal of pharmacology.

Drug discrimination and receptor binding studies of N-isopropyl lysergamide derivatives

D. Marona-Lewicka, D. Nichols, Xuemei Huang, 1994, Pharmacology Biochemistry and Behavior.

Complex stimulus properties of LSD: a drug discrimination study with α2-adrenoceptor agonists and antagonists

D. Marona-Lewicka, D. Nichols, 1995, Psychopharmacology.

Chronic LSD alters gene expression profiles in the mPFC relevant to schizophrenia

C. Nichols, D. Marona-Lewicka, D. Nichols, 2014, Neuropharmacology.

Further evidence that the delayed temporal dopaminergic effects of LSD are mediated by a mechanism different than the first temporal phase of action

D. Marona-Lewicka, D. Nichols, 2007, Pharmacology Biochemistry and Behavior.

Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis

R. Thisted, D. Marona-Lewicka, D. Nichols, 2005, Psychopharmacology.

Reinforcing effects of certain serotonin-releasing amphetamine derivatives

D. Marona-Lewicka, G. Rhee, D. Nichols, 1996, Pharmacology Biochemistry and Behavior.

Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI

D. Marona-Lewicka, D. Nichols, B. Chemel, 2009, Psychopharmacology.

Stability and variability of locomotor responses of laboratory rodents. IV. The responses of rats and mice to apomorphine and amphetamine.

J. Vetulani, D. Marona-Lewicka, 1988, Polish journal of pharmacology and pharmacy.

Stability and variability of locomotor responses of laboratory rodents. III. Effect of environmental factors and lack of catecholamine receptor correlates.

P. Popik, J. Michaluk, J. Vetulani, 1988, Polish journal of pharmacology and pharmacy.

Stability and variability of locomotor responses of laboratory rodents. II. Native exploratory and basal locomotor activity of Wistar rats.

P. Popik, J. Michaluk, J. Vetulani, 1987, Polish journal of pharmacology and pharmacy.

Stability and variability of locomotor responses of laboratory rodents. I. Native exploratory and basal locomotor activity of Albino-Swiss mice.

J. Michaluk, J. Vetulani, D. Marona-Lewicka, 1987, Polish journal of pharmacology and pharmacy.

The effect of chronic imipramine and electroconvulsive shock treatment on [3H]DADLE binding to cortical membranes of rats pretreated with chronic reserpine or 6-hydroxydopamine

J. Michaluk, J. Vetulani, D. Marona-Lewicka, 1987, Pharmacology Biochemistry and Behavior.

Potential serotonin 5-HT1A and dopamine D4 receptor modulation of the discriminative stimulus effects of amphetamine in rats

D. Marona-Lewicka, D. Nichols, 2011, Behavioural pharmacology.

Novel serotonergic agents.

M. P. Johnson, D. Marona-Lewicka, X. Huang, 1993, Drug design and discovery.

Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA).

D. Kurrasch, M. Parker, A. Shulgin, 1998, Journal of Medicinal Chemistry.

Synthesis and Pharmacological Examination of Benzofuran, Indan, and Tetralin Analogues of 3,4‐(Methylenedioxy)amphetamine.

N. Cozzi, D. Marona-Lewicka, A. Monte, 1994 .

p-methylthioamphetamine is a potent new non-neurotoxic serotonin-releasing agent.

D. Marona-Lewicka, X. Huang, D. Nichols, 1992, European journal of pharmacology.

Neurochemical correlates of differences in responses to psychotropic drugs. I. Apomorphine and morphine effects on locomotor activity of C57/BL and Balb/C mice.

J. Vetulani, D. Marona-Lewicka, 1989, Polish journal of pharmacology and pharmacy.

An animal model of schizophrenia based on chronic LSD administration: Old idea, new results

C. Nichols, D. Marona-Lewicka, D. Nichols, 2011, Neuropharmacology.

[Experimental model of depression: neurochemical changes and the effects of imipramine and citalopram].

N. K. Popova, D. Marona-Lewicka, N. Kudriavtseva, 1992, Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova.

Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine.

N. Cozzi, D. Marona-Lewicka, A. Monte, 1993, Journal of medicinal chemistry.

Aripiprazole (OPC-14597) fully substitutes for the 5-HT1A receptor agonist LY293284 in the drug discrimination assay in rats

D. Marona-Lewicka, D. Nichols, 2004, Psychopharmacology.

Stereoselective LSD-like activity in a series of d-lysergic acid amides of (R)- and (S)-2-aminoalkanes.

E. sanders-Bush, A. Kanthasamy, D. Marona-Lewicka, 1995, Journal of medicinal chemistry.